KemPharm (KMPH) CEO McFarlane received 700,000 Restricted Stock Unit
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Neil F. McFarlane (President and CEO at KemPharm Inc., KMPH) reported that they received 700,000 Restricted Stock Unit on Jan 31, 2024.
- Reporting person
- McFarlane Neil F.
- Role
- President and CEO
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 31, 2024 | Grant or award (A) | Restricted Stock UnitOn 700,000 Common Stock1, 2 | +700,000 | - | - | 700,000 direct |
Holdings before and after
- Restricted Stock Unit: 0 to 700,000 direct
Footnotes from the filing
- 1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Grant to the Reporting Person of restricted stock units ( RSU ).
- 2. The restricted stock units will vest and settle as to one third of the restricted stock units on January 31, 2025, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's ongoing employment.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did McFarlane report in this KMPH Form 4?
Neil F. McFarlane (President and CEO at KemPharm Inc., KMPH) reported that they received 700,000 Restricted Stock Unit on Jan 31, 2024.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for KMPH
Earlier insider filings at KMPH
- Feb 3, 2024SEC Form 4 filed by Shih Alvin
- Oct 11, 2023SEC Form 4 filed by Mcfarlane Neil F.
- Sep 6, 2023SEC Form 4: Schafer Joshua bought $2,564 worth of shares (500 units at $5.13), increasing direct ownership by 17% to 3,500 units
- Sep 6, 2023SEC Form 4: Clifton R. Laduane bought $4,959 worth of shares (1,000 units at $4.96), increasing direct ownership by 7% to 15,309 units
- Sep 6, 2023SEC Form 4: Bode John B bought $51,333 worth of shares (10,000 units at $5.13), increasing direct ownership by 100% to 20,000 units
Keep researching KMPH
- KMPH insider tradesEvery buy and sale reported by KemPharm Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
KMPH
KemPharm Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for KMPH
Full KMPH profile on Quantisnow Follow KMPH and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time